# Emulate, Inc.

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/emulate-inc
Canonical HTML page: https://gethealthbrief.com/entity/emulate-inc

## Timeline

- **2026-03-08**: Industry Consensus — Scientific American and other major outlets report a definitive decline in global animal experiment volumes.
- **2024-11-10**: Major CRO Pivot — Leading Contract Research Organizations announce multi-million dollar investments in digital twin and OOC labs.
- **2023-06-15**: FDA Guidance on NAMs — The FDA issues initial framework for the submission of data derived from microphysiological systems.
- **2022-12-29**: FDA Modernization Act 2.0 — President Biden signs legislation ending the mandate for animal testing for new drug applications.

## Recent coverage (1 stories)

### The Post-Animal Era: Regulatory Shifts and Tech Innovation Disrupt Drug R&D
2026-03-08 18:25:48 · Sentiment: Positive · Impact: 7/10 · Sources: 2

The long-standing paradigm of animal experimentation is facing an unprecedented decline as regulatory frameworks and advanced biotechnologies converge. Following the landmark FDA Modernization Act 2.0, the industry is pivoting toward 'New Approach Methodologies' that promise higher human predictive value and lower development costs.
Full story: https://gethealthbrief.com/story/animal-testing-decline-healthcare-regulation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.